Clinical Trial Update: A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors

View source ↗

Summary

This clinical trial update describes a study examining the gut microbiome in hormone receptor-positive, HER2-negative breast cancer treated with CDK4/6 inhibito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitors

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Breast Cancer | Status: RECRUITING